GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Celon Pharma CLN.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

16.30

0.00%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in PLN, from our data supplier.

FY2025

Revenue

PLN 209.8m

FY2016FY2025

Net income

−PLN 79.4m

FY2016FY2025

Free cash flow

−PLN 30.6m

FY2016FY2025

Shareholders' equity

PLN 363.2m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenuePLN 209.8mPLN 176.6mPLN 213.9mPLN 161.9mPLN 196.1mPLN 157.4mPLN 102.2mPLN 125.2mPLN 107.1mPLN 128.8m
Research and development——PLN 680,000PLN 680,000PLN 49.1mPLN 42.3m————
Operating income−PLN 56.8m−PLN 36.8m−PLN 27.2m−PLN 69.8m−PLN 13.5m−PLN 4.5mPLN 6.9mPLN 35.6mPLN 26.0mPLN 47.1m
Net income−PLN 79.4m−PLN 34.4m−PLN 28.1m−PLN 39.3m−PLN 11.6m−PLN 917,000PLN 11.9mPLN 29.7mPLN 25.6mPLN 37.8m
Diluted earnings per share-1.47-0.71-0.55-0.77-0.29-0.020.270.660.570.84

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsPLN 457.5mPLN 543.8mPLN 569.3mPLN 608.9mPLN 707.1mPLN 703.6mPLN 591.3mPLN 563.7mPLN 525.0mPLN 464.3m
Cash and short-term investmentsPLN 19.9mPLN 56.5mPLN 114.5mPLN 164.6mPLN 227.6mPLN 44.0mPLN 66.7mPLN 148.0mPLN 200.9mPLN 221.9m
Total liabilitiesPLN 74.5mPLN 98.6mPLN 123.8mPLN 129.3mPLN 153.1mPLN 269.0mPLN 146.3mPLN 114.9mPLN 85.2mPLN 61.8m
DebtPLN 18.9mPLN 16.9mPLN 25.6mPLN 26.8mPLN 14.9mPLN 25.5mPLN 1.7mPLN 954,115PLN 3.3mPLN 6.2m
Shareholders' equityPLN 363.2mPLN 445.2mPLN 445.6mPLN 479.6mPLN 554.0mPLN 344.5mPLN 445.0mPLN 448.7mPLN 439.8mPLN 402.5m
Shares outstanding54m49m51m51m41m45m45m45m45m45m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsPLN 23.9m−PLN 11.3m−PLN 8.3m−PLN 4.7mPLN 44.0mPLN 70.9m−PLN 5.1mPLN 28.2mPLN 25.3mPLN 20.6m
Capital spending−PLN 54.4m−PLN 22.8m−PLN 32.8m−PLN 33.9m−PLN 41.4m−PLN 99.2m−PLN 65.0m−PLN 67.5m−PLN 31.3m−PLN 21.3m
Free cash flow−PLN 30.6m−PLN 34.1m−PLN 41.1m−PLN 38.6mPLN 2.6m−PLN 28.3m−PLN 70.0m−PLN 39.2m−PLN 6.0m−PLN 641,176
Dividends paid—−PLN 4.1m−PLN 4.6m−PLN 14.8m−PLN 3.1m−PLN 3.6m−PLN 7.2m−PLN 7.7m−PLN 7.7m−PLN 4.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenuePLN 49.1mPLN 57.5mPLN 54.0mPLN 51.7mPLN 56.6mPLN 49.1mPLN 37.5mPLN 50.7m
Operating income−PLN 14.0m−PLN 10.3m−PLN 7.4mPLN 8.1m−PLN 16.7m−PLN 18.8m−PLN 68.8mPLN 56.7m
Net income−PLN 30.6mPLN 162.6m−PLN 24.9mPLN 3.7m−PLN 32.8m−PLN 25.1m−PLN 67.9mPLN 57.2m
Diluted earnings per share-0.573.02-0.460.07-0.61-0.47-1.391.17
Cash from operations—−PLN 4.0mPLN 36.0m−PLN 4.0mPLN 3.0m−PLN 11.0mPLN 13.0m−PLN 14.0m
Capital spending−PLN 40.0m−PLN 14.0m−PLN 26.0m−PLN 2.0m−PLN 22.0m−PLN 3.0m−PLN 13.0m−PLN 4.0m
Free cash flow—−PLN 18.0mPLN 10.0m−PLN 6.0m−PLN 19.0m−PLN 14.0mPLN 0−PLN 18.0m
Total assetsPLN 733.4mPLN 670.7mPLN 457.5mPLN 471.3mPLN 482.6mPLN 522.6mPLN 543.8mPLN 619.2m
Cash and short-term investments—PLN 9.1mPLN 19.9mPLN 1.7mPLN 39.0mPLN 52.5mPLN 56.5mPLN 103.3m
DebtPLN 77.9mPLN 21.4mPLN 8.8mPLN 7.7mPLN 12.3mPLN 12.3mPLN 8.7mPLN 7.1m
Shareholders' equityPLN 498.6mPLN 528.8mPLN 363.2mPLN 389.2mPLN 385.1mPLN 419.5mPLN 445.2mPLN 516.2m

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2014FY2013
Operating margin-23.2%-17.8%-8.1%-21.5%-6.9%-2.6%——
Net margin-32.5%-16.6%-13.1%-24.3%-5.9%-0.6%——
Return on equity-21.8%-7.7%-6.3%-8.2%-2.1%-0.3%——
Return on assets-17.3%-6.3%-4.9%-6.5%-1.6%-0.1%——
Free cash flow yield8.6%1.4%2.8%3.4%12.5%22.5%——
Revenue growth17.9%-3.1%32.1%-17.4%24.5%54.0%——
Earnings growth130.4%22.5%-28.4%238.4%1165.8%-107.7%——
Current ratio1.62x2.40x2.20x2.04x3.23x1.04x——
Debt to equity0.02x0.02x0.04x0.04x0.01x0.05x——
Equity ratio79.4%81.9%78.3%78.8%78.3%49.0%——
Interest coverage-35.54x-14.93x-6.49x-20.81x-8.71x-2.94x——
R&D as a share of sales——0.3%0.4%25.0%26.8%9.0%6.2%
Buybacks as a share of market value-10.4%5.0%-0.7%-25.7%9.8%0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.0%5.9%6.9%
Operating income-6.6%65.8%—
Net income26.4%144.0%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-24.2%-25.0%-18.7%-2.7%
Net margin-29.5%-23.8%-17.4%-3.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-13.8-37.5-28.2-18.2-116.0-1989.9149.747.462.929.2
Price to sales5.27.33.74.46.911.617.511.215.08.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Jun 2024.

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Paid in the year0.080.090.290.070.080.240.170.17

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.